Possible Causes of Failing to Meet Primary Endpoints: A Systematic Review of Randomized Controlled Phase 3 Clinical Trials in Patients With Non–Small Cell Lung Cancer

被引：0
|
作者：
Mitsugu Ikeda
Tatsuya Ochibe
Masahiro Tohkin
机构：
[1] Nagoya City University,Department of Regulatory Science, Graduate School of Pharmaceutical Sciences
来源：
Therapeutic Innovation & Regulatory Science | 2019年 / 53卷
关键词：
phase 3 clinical trial; systematic review; non—small cell lung cancer; primary endpoint; success rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：324 / 331
页数：7
相关论文
共 50 条
  • [1] Possible Causes of Failing to Meet Primary Endpoints: A Systematic Review of Randomized Controlled Phase 3 Clinical Trials in Patients With Non-Small Cell Lung Cancer
    Ikeda, Mitsugu
    Ochibe, Tatsuya
    Tohkin, Masahiro
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (03) : 324 - 331
  • [2] Prophylactic Cranial Irradiation in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Al Feghali, Karine A.
    Ballout, Rami A.
    Khamis, Assem M.
    Akl, Elie A.
    Geara, Fady B.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] Neoadjuvant Immunotherapy and Non-Small Cell Lung Cancer A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Yu, Shaofu
    Zhai, Shasha
    Gong, Qian
    Xiang, Chunhong
    Gong, Jianping
    Wu, Lin
    Pu, Xingxiang
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (11): : 517 - 528
  • [4] Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer
    Fernandez-Lopez, Cristina
    Exposito-Hernandez, Jose
    Pedro Arrebola-Moreno, Juan
    Angel Calleja-Hernandez, Miguel
    Exposito-Ruiz, Manuela
    Guerrero-Tejada, Rosa
    Linares, Isabel
    Cabeza-Barrera, Jose
    CANCER MEDICINE, 2016, 5 (09): : 2190 - 2197
  • [5] Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials
    Xiao, Zheng
    Wang, Chengqiong
    Tan, Zhouke
    Hu, Shanshan
    Chen, Yali
    Zhou, Minghua
    Feng, Jihong
    Liu, Shiyu
    Chen, Ling
    Ding, Jie
    Gong, Qihai
    Tang, Fushan
    Liu, Hui
    Li, Xiaofei
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (01) : 23 - 38
  • [6] The Reporting Completeness of Patient-Reported Outcome in Randomized Controlled Trials of Non-Small Cell Lung Cancer Could Be Improved: A Systematic Review
    He, Wenbo
    Jing, Fangyuan
    Gao, Yinyan
    Yi, Hang
    Li, Meixuan
    You, Jiuhong
    Shen, Yanjiao
    Wu, Yi
    Kang, Pan
    Yu, Zhiruo
    Wang, Xinyi
    Luo, Yunmei
    Li, Zhengchi
    Du, Liang
    PSYCHO-ONCOLOGY, 2025, 34 (04)
  • [7] Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials
    Levy, Antonin
    Gomez-Roca, Carlos
    Massard, Christophe
    Planchard, David
    Albiges, Laurence
    Bahleda, Ratislav
    Bourgier, Celine
    Deutsch, Eric
    Soria, Jean Charles
    Besse, Benjamin
    ONKOLOGIE, 2013, 36 (06): : 357 - 362
  • [8] Systematic Review of Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer
    Cao, Christopher
    Guo, Allen
    Chen, Christopher
    Chakos, Adam
    Bott, Matthew
    Yang, Chi-Fu Jeffrey
    Zielinski, Rob
    Melfi, Franca
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (03) : 850 - 857
  • [9] Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer A systematic review and meta-analysis of randomized controlled trials
    Tan, Xinmei
    Liang, Xueyan
    Xi, Jiaxi
    Guo, Sitong
    Meng, Mingyu
    Chen, Xiaoyu
    Li, Yan
    MEDICINE, 2021, 100 (36) : E27161
  • [10] Clinical Efficacy of Osimertinib in Targeted Therapies of Patients with Non Small Cell Lung Cancer A Randomized Controlled Trial
    Zhuo, De-bin
    Zheng, Gui-lin
    Lin, Qing-yu
    Lin, Juan
    Wang, Shan-zuan
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2021, 43 (06): : 879 - 887
12345